These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10077522)

  • 1. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.
    Kumar A; Villani MP; Patel UK; Keith JC; Schaub RG
    Circulation; 1999 Mar; 99(10):1363-9. PubMed ID: 10077522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety of recombinant P-selectin glycoprotein ligand-immunoglobulin G fusion protein in experimental models of localized and systemic infection.
    Opal SM; Sypek JP; Keith JC; Schaub RG; Palardy JE; Parejo NA
    Shock; 2001 Apr; 15(4):285-90. PubMed ID: 11303727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant P-selectin glycoprotein ligand-immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial.
    Mertens P; Maes A; Nuyts J; Belmans A; Desmet W; Esplugas E; Charlier F; Figueras J; Sambuceti G; Schwaiger M; Mortelmans L; Van de Werf F;
    Am Heart J; 2006 Jul; 152(1):125.e1-8. PubMed ID: 16824841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine.
    Bienvenu JG; Tanguay JF; Théorêt JF; Kumar A; Schaub RG; Merhi Y
    Circulation; 2001 Feb; 103(8):1128-34. PubMed ID: 11222477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.
    Myers DD; Henke PK; Wrobleski SK; Hawley AE; Farris DM; Chapman AM; Knipp BS; Thanaporn P; Schaub RG; Greenfield LJ; Wakefield TW
    J Vasc Surg; 2002 Nov; 36(5):928-38. PubMed ID: 12422103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.
    Wang K; Zhou Z; Zhou X; Tarakji K; Topol EJ; Lincoff AM
    J Am Coll Cardiol; 2001 Aug; 38(2):577-82. PubMed ID: 11499755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1.
    Tanguay JF; Geoffroy P; Sirois MG; Libersan D; Kumar A; Schaub RG; Merhi Y
    Thromb Haemost; 2004 Jun; 91(6):1186-93. PubMed ID: 15175806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model.
    Amersi F; Dulkanchainun T; Nelson SK; Farmer DG; Kato H; Zaky J; Melinek J; Shaw GD; Kupiec-Weglinski JW; Horwitz LD; Horwitz MA; Busuttil RW
    Transplantation; 2001 Jan; 71(1):112-8. PubMed ID: 11211175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.
    Wakefield TW; Strieter RM; Schaub R; Myers DD; Prince MR; Wrobleski SK; Londy FJ; Kadell AM; Brown SL; Henke PK; Greenfield LJ
    J Vasc Surg; 2000 Feb; 31(2):309-24. PubMed ID: 10664500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reocclusion after thrombolysis: a problem solved by hirudin?
    Rübsamen K; Eschenfelder V
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):97-100. PubMed ID: 1773004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)- ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate in a canine model of femoral thrombosis.
    Higo K; Karasawa A; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1251-5. PubMed ID: 1815525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation.
    Théorêt JF; Chahrour W; Yacoub D; Merhi Y
    Br J Pharmacol; 2006 Jun; 148(3):299-305. PubMed ID: 16633357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ; Prager NA; Sobel BE; Abendschein DR
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits.
    Rübsamen K; Eschenfelder V
    Haemostasis; 1991; 21 Suppl 1():93-8. PubMed ID: 1894200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble P-selectin antagonist mediates rolling velocity and adhesion of leukocytes in acutely inflamed venules.
    Eppihimer MJ; Schaub RG
    Microcirculation; 2001 Feb; 8(1):15-24. PubMed ID: 11296849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
    Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
    Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of reocclusion by MCI-9038, a thrombin inhibitor, following t-PA-induced thrombolysis in a canine model of femoral arterial thrombosis.
    Mellott MJ; Connolly TM; York SJ; Bush LR
    Thromb Haemost; 1990 Dec; 64(4):526-34. PubMed ID: 2128137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.